Insider buying last 90 days
No open-market insider purchases were filed for PLXS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Sep 28 close
Plexus draws attention this week on the back of an analyst upgrade, with Keybanc raising the stock to Overweight and setting a $300 price target, citing growth prospects in the Aerospace/Defense and Industrial segments and expectations of over 20% growth in FY27. Separately, brokerages have given the company a consensus "Buy" rating with an average 12-month price target of $276.86, following its recent quarterly results, which showed EPS of $2.32 and revenue of $1.30 billion, up 28.2% year-over-year. A comparison piece also weighs Plexus against peer Vontier on profitability, valuation and analyst recommendations.
Plexus closed at $264.96, up 0.7%, sitting above both its 50-day average of $253.39 and its 200-day average of $229.64, with the shorter average also above the longer one. The GekkoIndex reads 50.5, placing the stock in the Neutral zone, down 6.6 over five days. Price stands 15.7% above Gekko Fair Value of $228.99.
The next earnings date falls on 28 October 2026, before the open, which lies outside a typical 20-trading-day holding window; the prior report on 29 July showed EPS of $1.58 against an estimate of $1.27, with a 3.2% reaction. No insider, Congress or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged a 2.9% return over 5 years, rising in 4 of them, a pattern worth noting alongside the current 15% consensus upside cited by covering analysts.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Plexus scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Above 50 and 200-day
Close $264.96 is above the 50-day ($253.39) and 200-day ($229.64) averages, and the 50-day is above the 200-day.
See the chart50.5, Neutral
Reading 50.5 is in the Neutral zone.
See the GekkoIndex15.7% above
Price is 15.7% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 29 days
Next report Oct 28, 2026, 29 days away — outside a typical 20-trading-day hold.
See earnings+2.9% on average
From this point in the calendar, the next 20 trading days averaged +2.9% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Plexus closed at $264.96 on Sep 28, 2026, +88.0% over the past year, inside a 52-week range of $132.03 to $307.06.
Use the left and right arrow keys to read daily values.
Put PLXS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Plexus provides electronic manufacturing services to businesses around the world, with operations spanning the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Its work covers the full product lifecycle, from design and development through supply chain management, new product introduction support, manufacturing itself, and aftermarket services once products are in use.
The company organizes its offerings around a set of customer segments, serving businesses in healthcare and life sciences, industrial and commercial markets, aerospace and defense, and communications. This structure allows Plexus to support clients through each stage of bringing electronic products to market and maintaining them afterward.
Plexus was established in 1979 and is headquartered in Neenah, Wisconsin. Its shares are listed on the NASDAQ under the ticker PLXS.
Plexus’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 50.5, in the Neutral zone, down 6.6 points over five sessions.
Down 6.6 points over five sessions.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 33 | +0.5% | −0.7% | ||
| Accumulation | 164 | +1.1% | +2.6% | ||
| Neutral (current zone) | 408 | +0.9% | +4.0% | ||
| Distribution | 65 | +0.5% | +3.0% | ||
| Selling | 2 | Too few readings yet | |||
Average PLXS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Plexus trades 15.7% above Gekko Fair Value of $228.99, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Plexus shares are worth, recalculated every trading day.
$228.99
Gekko Fair Value, Sep 26, 2026
15.7% Overvalued
No open-market insider purchases were filed for Plexus, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for PLXS in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in PLXS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Plexus has been buying back its own shares.
From company filings.
Plexus reports on Oct 28, 2026, before the open (29 days away), and beat the EPS estimate in 7 of its last 8 reports.
Oct 28, 2026
Expected before the open, 29 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $1.58 est $1.27 | $1.30B est $1.23B | −3.2% |
| Apr 29, 2026 | $2.05 est $1.88 | $1.16B est $1.13B | +1.7% |
| Jan 28, 2026 | $1.78 est $1.77 | $1.07B est $1.07B | +13.9% |
| Oct 22, 2025 | $2.14 est $1.87 | $1.06B est $1.05B | −0.3% |
| Jul 23, 2025 | $1.90 est $1.71 | $1.02B est $1.08B | −11.5% |
| Apr 23, 2025 | $1.66 est $1.54 | $980.2M est $1.03B | +1.0% |
| Jan 22, 2025 | $1.34 est $1.39 | $976.1M est $982.3M | −10.0% |
| Oct 23, 2024 | $1.85 est $1.55 | $1.05B est $1.01B | +7.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Plexus is $304.60, +15.0% from the last close, from 5 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 5 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 22 | KeyBanc | $300 | +13.2% |
| Sep 21 | KeyBanc | $300 | +13.2% |
| Aug 28 | Stifel Nicolaus | $330 | +24.5% |
| Aug 14 | Needham | $310 | +17.0% |
| Jul 31 | KeyBanc | — | — |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 26, Plexus averaged +2.9% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.6% | 4 of 5 |
| Next 10 trading days | +1.0% | 4 of 5 |
| Next 15 trading days | +3.6% | 4 of 5 |
| Next 20 trading days | +2.9% | 4 of 5 |
| Next 30 trading days | +10.5% | 4 of 5 |
For scale, PLXS’s typical 20-trading-day move in either direction is about 5.3%.
Plexus’s market cap is $7.09B, with a P/E ratio of 38.8 and revenue of $4.60B over the last twelve months.
3 headlines about Plexus from the past week, newest first, each linking to the publisher.
Plexus’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| VRTVertiv | Accumulation | 9.9% below |
| BEBloom Energy | Neutral | 5.7% above |
| TERTeradyne | Neutral | 9.8% above |
| FLEXFlex | Neutral | 1.4% below |
| SANMSanmina | Neutral | 7.9% above |
| AEISAdvanced Energy Industries | Neutral | 8.6% below |
A peer links to its own page where one exists.
Plexus’s market cap is $7.09B at the Sep 28, 2026 close of $264.96, with 26.65M shares outstanding. The shares trade on a P/E ratio of 38.8.
The consensus analyst 12-month price target for Plexus is $304.60, +15.0% from the last close. Of the 5 firms that rated the stock in the last 90 days, 5 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Plexus is overvalued: the Sep 28, 2026 close of $264.96 is 15.7% above Gekko Fair Value of $228.99. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Plexus is expected to report on Oct 28, 2026, before the market opens (29 days away). Analysts expect earnings of $2.57 per share on revenue of $1.36B. Plexus beat the earnings estimate in 7 of its last 8 reports, moving 6.1% on average across the report.
Plexus’s 52-week high is $307.06 and its 52-week low is $132.03; it closed at $264.96 on Sep 28, 2026, +88.0% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.